Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/03/22
End: 10/27/23
Due: 10/27/24
Phase: N/A
Priority: Normal
Start: 08/17/22
End: 08/14/23
Due: 08/14/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule,Zephir Inhaler Device | NCT06254664 | Xiromed LLC | user2@example.com | None | 2022-10-03 | 2023-10-27 | 2024-10-27 | - | - | 2025-07-14 |
| Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD) | NCT05986591 | Xiromed LLC | user2@example.com | None | 2022-08-17 | 2023-08-14 | 2024-08-14 | - | - | 2025-07-14 |